Interestingly, higher AXL/GAS6 levels could be detected in stem cell-enriched Lin–CD34+CD38– cells from AML patients harboring mixed lineage leukemia (MLL) fusions compared to non-MLL samples. The gene discussed is KMT2A; the disease is acute myeloid leukemia.